Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Mariëtte I.E. van Poelgeest"'
Autor:
Sjoerd H. van der Burg, Cornelis J.M. Melief, Hans W. Nijman, Theo Stijnen, Gemma G. Kenter, Tjalling Bosse, Gertjan J. Fleuren, J. Hanneke N.G. Oude Elberink, Jaap Oostendorp, A. Rob P.M. Valentijn, Harry Hollema, Toos Daemen, Lorraine M. Fathers, J. Baptist M.Z. Trimbos, Marjolein J. Kagie, Henk W. Schreuder, Marc van Beurden, Bart W.J. Hellebrekers, Edith M.G. van Esch, Ineke L.E. Hamming, Margriet J.G. Löwik, Dorien M.A. Berends-van der Meer, Nikki M. Loof, Linda F.M. Stynenbosch, Renee Vermeij, Marij J.P. Welters, Mariëtte I.E. van Poelgeest
Purpose: Therapeutic vaccination with human papillomavirus type 16 (HPV16) E6 and E7 synthetic long peptides (SLP) is effective against HPV16-induced high-grade vulvar and vaginal intraepithelial neoplasia (VIN/VaIN). However, clinical nonresponders
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90fd8ad0b57ff48e3408370a9dbd37d4
https://doi.org/10.1158/1078-0432.c.6524177.v1
https://doi.org/10.1158/1078-0432.c.6524177.v1
Autor:
Sjoerd H. van der Burg, Cornelis J.M. Melief, Hans W. Nijman, Theo Stijnen, Gemma G. Kenter, Tjalling Bosse, Gertjan J. Fleuren, J. Hanneke N.G. Oude Elberink, Jaap Oostendorp, A. Rob P.M. Valentijn, Harry Hollema, Toos Daemen, Lorraine M. Fathers, J. Baptist M.Z. Trimbos, Marjolein J. Kagie, Henk W. Schreuder, Marc van Beurden, Bart W.J. Hellebrekers, Edith M.G. van Esch, Ineke L.E. Hamming, Margriet J.G. Löwik, Dorien M.A. Berends-van der Meer, Nikki M. Loof, Linda F.M. Stynenbosch, Renee Vermeij, Marij J.P. Welters, Mariëtte I.E. van Poelgeest
supplementary material and methods Table S1. Reasons for exclusion of patients from outcome analysis Table S2. Summary statistics of patient groups according to linear mixed model analysis Table S3. All related systemic adverse events by study group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21b8a6677f65bf9841f179d57ec0aef3
https://doi.org/10.1158/1078-0432.22459244.v1
https://doi.org/10.1158/1078-0432.22459244.v1
Autor:
Sjoerd H. van der Burg, Marij J.P. Welters, Mariëtte I.E. van Poelgeest, Peggy J. de Vos van Steenwijk, Kim E. Kortekaas, Sylvia L. van Egmond, Lilly-Ann van der Velden, Thomas Höllt, Vincent van Unen, Chantal L. Duurland, Pornpimol Charoentong, Ilina Ehsan, Vanessa J. van Ham, Saskia J. Santegoets
Supplemental tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c9ad719f25ece1ed7e1469c7d2d73bc
https://doi.org/10.1158/1078-0432.22475007.v1
https://doi.org/10.1158/1078-0432.22475007.v1
Autor:
Sjoerd H. van der Burg, Marij J.P. Welters, Mariëtte I.E. van Poelgeest, Peggy J. de Vos van Steenwijk, Kim E. Kortekaas, Sylvia L. van Egmond, Lilly-Ann van der Velden, Thomas Höllt, Vincent van Unen, Chantal L. Duurland, Pornpimol Charoentong, Ilina Ehsan, Vanessa J. van Ham, Saskia J. Santegoets
Purpose:The tumor immune microenvironment determines clinical outcome. Whether the original tissue in which a primary tumor develops influences this microenvironment is not well understood.Experimental Design:We applied high-dimensional single-cell m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75cdfb8f59eb173ab207b11ae4743fee
https://doi.org/10.1158/1078-0432.c.6528966
https://doi.org/10.1158/1078-0432.c.6528966
Autor:
Sjoerd H. van der Burg, Marij J.P. Welters, Mariëtte I.E. van Poelgeest, Peggy J. de Vos van Steenwijk, Kim E. Kortekaas, Sylvia L. van Egmond, Lilly-Ann van der Velden, Thomas Höllt, Vincent van Unen, Chantal L. Duurland, Pornpimol Charoentong, Ilina Ehsan, Vanessa J. van Ham, Saskia J. Santegoets
Supplemental figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0674b04975698b1f0c374413fb4ea809
https://doi.org/10.1158/1078-0432.22475010.v1
https://doi.org/10.1158/1078-0432.22475010.v1
Autor:
Rianne Rijneveld, M. Rijsbergen, S.T.P. Kouwenhoven, Robert Rissmann, Marina Todd, Erica S. Klaassen, Mariëtte I.E. van Poelgeest, Koen D. Quint, G. Feiss, Maurits N. C. de Koning, Jacobus Burggraaf, Dirk C.J.G. van Alewijk
Publikováno v:
British Journal of Clinical Pharmacology, 86(11), 2133-2143
Br J Clin Pharmacol
British Journal of Clinical Pharmacology, 86(11), 2133-2143. WILEY
Br J Clin Pharmacol
British Journal of Clinical Pharmacology, 86(11), 2133-2143. WILEY
AIMS\nMETHODS\nRESULTS\nCONCLUSION\n To assess safety and tolerability and explore pharmacodynamics and efficacy of omiganan in external anogenital warts (AGW) and vulvar high-grade squamous intraepithelial lesions (HSIL).\nTwo randomized controlled
Autor:
Geke A. P. Hospers, Karijn P M Suijkerbuijk, Marye J Boers-Sonderen, Albert J. ten Tije, Ellen Kapiteijn, Liesbeth C. de Wreede, Michiel C T van Zeijl, Florine L. Boer, Gerard Vreugdenhil, Michel W.J.M. Wouters, Franchette W P J van den Berkmortel, Rozemarijn S. van Rijn, Djura Piersma, Astrid A M van der Veldt, Jan Willem B. de Groot, Mariëtte I.E. van Poelgeest, John B. A. G. Haanen, Alfons J. M. van den Eertwegh, Maureen J.B. Aarts
Publikováno v:
European Journal of Cancer, 137, 127-135
van Zeijl, M C T, Boer, F L, van Poelgeest, M I E, van den Eertwegh, A J M, Wouters, M W J M, de Wreede, L C, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J W B, Hospers, G A P, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, ten Tije, A J, van der Veldt, A A M, Vreugdenhil, G, Boers-Sonderen, M J, Kapiteijn, E H W & Haanen, J B A G 2020, ' Survival outcomes of patients with advanced mucosal melanoma diagnosed from 2013 to 2017 in the Netherlands – A nationwide population-based study ', European Journal of Cancer, vol. 137, pp. 127-135 . https://doi.org/10.1016/j.ejca.2020.05.021
European Journal of Cancer, 137, 127-135. Pergamon
European Journal of Cancer, 137, 127-135. ELSEVIER SCI LTD
European Journal of Cancer, 137, pp. 127-135
European Journal of Cancer, 137, 127-135. Elsevier Ltd.
van Zeijl, M C T, Boer, F L, van Poelgeest, M I E, van den Eertwegh, A J M, Wouters, M W J M, de Wreede, L C, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J W B, Hospers, G A P, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, ten Tije, A J, van der Veldt, A A M, Vreugdenhil, G, Boers-Sonderen, M J, Kapiteijn, E H W & Haanen, J B A G 2020, ' Survival outcomes of patients with advanced mucosal melanoma diagnosed from 2013 to 2017 in the Netherlands – A nationwide population-based study ', European Journal of Cancer, vol. 137, pp. 127-135 . https://doi.org/10.1016/j.ejca.2020.05.021
European Journal of Cancer, 137, 127-135. Pergamon
European Journal of Cancer, 137, 127-135. ELSEVIER SCI LTD
European Journal of Cancer, 137, pp. 127-135
European Journal of Cancer, 137, 127-135. Elsevier Ltd.
Background: Mucosal melanoma (MM) is rare and has a poor prognosis. Since 2011, new effective treatments are available for advanced melanoma. It is unclear whether patients with mucosal melanoma equally benefit from these new treatments compared with
Autor:
Ming Y. Tjiong, Geoff Hughes, Joanne A. de Hullu, Nan van Geloven, Marta Jozwiak, L.S. Nooij, Katja N. Gaarenstroom, Mieke L.G. ten Eikelder, Florine L. Boer, Mariëtte I.E. van Poelgeest, Ellen H. Kapiteijn, Khadra Galaal
Publikováno v:
Gynecologic Oncology, 161, 1, pp. 202-210
Gynecologic Oncology, 161(1), 202-210. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic Oncology, 161(1), 202-210. Academic Press
Gynecologic Oncology, 161, 202-210
Gynecologic Oncology, 161(1), 202-210. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic Oncology, 161(1), 202-210. Academic Press
Gynecologic Oncology, 161, 202-210
Objective. To identify clinicopathological characteristics, treatment patterns, clinical outcomes and prognostic factors in patients with vulvar melanoma (VM). Materials & methods. This retrospective multicentre cohort study included 198 women with V
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efec3d15bef40bc4f54bc7d6c98949b8
https://hdl.handle.net/1887/3276347
https://hdl.handle.net/1887/3276347
Autor:
Mignon Dingena Johanna Maria van Gent, Johanna Cornelia Bernadette van der Veer, Mandy Rademaker, Cor D. de Kroon, Johannes Baptist Maria Zacharias Trimbos, Hein Putter, Katja N. Gaarenstroom, Mariëtte I.E. van Poelgeest
Publikováno v:
International Journal of Gynecological Cancer, 27(8), 1729-1736
International journal of gynecological cancer, 27(8), 1729-1736. Wolters Kluwer Health
International journal of gynecological cancer, 27(8), 1729-1736. Wolters Kluwer Health
Objectives Nerve-sparing radical hysterectomy for early stage cervical cancer was introduced to improve quality of life after treatment. Sparing the pelvic autonomic nerves reduces bladder, bowel, and sexual dysfunction. The Leiden nerve-sparing radi
Autor:
Saskia J. A. M. Santegoets, Ilina Ehsan, Marij van der Tol, Helena C. van Doorn, Sjoerd H. van der Burg, Tjalling Bosse, Vanessa J. van Ham, Kim E. Kortekaas, Ziena Abdulrahman, Mariëtte I.E. van Poelgeest
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
Journal for ImmunoTherapy of Cancer, 7(1):236. BioMed Central Ltd.
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, 7(1)
Journal for ImmunoTherapy of Cancer, 7(1):236. BioMed Central Ltd.
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, 7(1)
Background Vulvar squamous cell carcinoma (VSCC) has been suggested to consist of three subtypes; HPV-positive, HPV-negative mutated TP53 or HPV-negative TP53 wildtype, with different clinical courses. To analyze the immune infiltrate in these molecu